European Healthtech startup funding raised during H1 2010.
In H1 2010, 23 European Healthtech companies raised a combined €207M across 23 funding rounds, up 48.8% versus H1 2009. Germany led by capital raised, and High-Tech Gr√ºnderfonds (HTGF) was the most active investor. Data as of 7 Aug 2026.
1 exit · €155M disclosed.
| Acquisition |
| May 2010 |
| €155M |
| €21M |
| CeQur | Series A | Jan 2010 | €21M |
| Genticel | Series C | Apr 2010 | €13M |
| Valtech Cardio | Series B | Mar 2010 | €13M |
| Nanobiotix | Other | May 2010 | €9.9M |
| Funxional Therapeutics | Series B | May 2010 | €9.2M |
| TCD Pharma | Other | Mar 2010 | €8.0M |
| Carebase | Early VC | May 2010 | €6.7M |
| Pharnext | Other | Jun 2010 | €5.2M |
| Oncos Therapeutics | Other | Apr 2010 | €5.0M |
| Veryan Medical | Series B | Apr 2010 | €4.0M |
| ActiViews | Series B | Jan 2010 | €3.5M |
